GR3026209T3 - Compositions containing quinolone antibiotics and sulfonate of polystyrol. - Google Patents
Compositions containing quinolone antibiotics and sulfonate of polystyrol.Info
- Publication number
- GR3026209T3 GR3026209T3 GR980400386T GR980400386T GR3026209T3 GR 3026209 T3 GR3026209 T3 GR 3026209T3 GR 980400386 T GR980400386 T GR 980400386T GR 980400386 T GR980400386 T GR 980400386T GR 3026209 T3 GR3026209 T3 GR 3026209T3
- Authority
- GR
- Greece
- Prior art keywords
- quinolones
- compositions containing
- polystyrol
- sulfonate
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76110491A | 1991-09-17 | 1991-09-17 | |
| PCT/US1992/007744 WO1993005816A1 (en) | 1991-09-17 | 1992-09-11 | Compositions containing quinolone antibiotics and sulfonate of polystyrol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3026209T3 true GR3026209T3 (en) | 1998-05-29 |
Family
ID=25061139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR980400386T GR3026209T3 (en) | 1991-09-17 | 1998-02-25 | Compositions containing quinolone antibiotics and sulfonate of polystyrol. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5679336A (el) |
| EP (1) | EP0604570B1 (el) |
| AT (1) | ATE162081T1 (el) |
| AU (1) | AU2672892A (el) |
| DE (1) | DE69224071T2 (el) |
| DK (1) | DK0604570T3 (el) |
| ES (1) | ES2111083T3 (el) |
| GR (1) | GR3026209T3 (el) |
| WO (1) | WO1993005816A1 (el) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2106680B1 (es) * | 1995-08-03 | 1998-07-01 | Vita Invest Sa | Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes. |
| US5695882A (en) * | 1995-08-17 | 1997-12-09 | The University Of Montana | System for extracting soluble heavy metals from liquid solutions |
| ID21415A (id) | 1997-12-05 | 1999-06-10 | Upjohn Co | Senyawa-senyawa antibiotik magnesium quinolon |
| US6270755B1 (en) * | 1999-05-13 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Anionic polymers as toxin binders |
| EP1800687A3 (en) * | 1999-05-13 | 2009-12-30 | Genzyme Corporation | Anionic polymers as toxin binders and antibacterial agents |
| US6290946B1 (en) | 1999-05-13 | 2001-09-18 | Geltex Pharmaceuticals, Inc. | Anionic polymers as toxin binders and antibacterial agents |
| US6514492B1 (en) | 1999-07-14 | 2003-02-04 | Schering-Plough Veterinary Corporation | Taste masking of oral quinolone liquid preparations using ion exchange resins |
| CZ302919B6 (cs) * | 1999-07-14 | 2012-01-18 | Schering-Plough Ltd. | Vodný farmaceutický prostredek |
| PL201130B1 (pl) | 1999-09-24 | 2009-03-31 | Alcon Inc | Kompozycje zawiesinowe zawierające ciprofloksacynę i deksametazon do podawania miejscowego do oczu, uszu lub nosa |
| JP2003513046A (ja) | 1999-11-01 | 2003-04-08 | アルコン，インコーポレイテッド | フルオロキノロン抗生薬およびキサンタンガムを含有する薬学的組成物 |
| CA2314494A1 (en) | 2000-05-02 | 2001-11-02 | Geltex Pharmaceuticals, Inc. | Anionic polymers as species specific antibacterial agents |
| CN1218689C (zh) | 2000-07-28 | 2005-09-14 | 爱尔康公司 | 包含妥布霉素和黄原胶的药物组合物 |
| US6743439B1 (en) * | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
| EP1429780B1 (en) * | 2001-09-21 | 2005-12-21 | Alcon, Inc. | Method of treating middle ear infections |
| JP2006151808A (ja) * | 2002-12-24 | 2006-06-15 | Dai Ichi Seiyaku Co Ltd | 抗菌性水性製剤 |
| DE102006010643A1 (de) * | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
| CA2752296C (en) * | 2009-02-18 | 2018-09-11 | Aradigm Corporation | Ph-modulated formulations for pulmonary delivery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53141286A (en) * | 1977-05-16 | 1978-12-08 | Kyorin Seiyaku Kk | Novel substituted quinolinecarboxylic acid |
| CA1175836A (en) * | 1977-09-20 | 1984-10-09 | Marcel Pesson | Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives |
| JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
| US4615882A (en) * | 1982-09-27 | 1986-10-07 | Stockel Richard F | Disinfectant solution for contact lens |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
-
1992
- 1992-09-11 DE DE69224071T patent/DE69224071T2/de not_active Expired - Fee Related
- 1992-09-11 DK DK92920802T patent/DK0604570T3/da active
- 1992-09-11 AT AT92920802T patent/ATE162081T1/de not_active IP Right Cessation
- 1992-09-11 AU AU26728/92A patent/AU2672892A/en not_active Abandoned
- 1992-09-11 WO PCT/US1992/007744 patent/WO1993005816A1/en active IP Right Grant
- 1992-09-11 ES ES92920802T patent/ES2111083T3/es not_active Expired - Lifetime
- 1992-09-11 EP EP92920802A patent/EP0604570B1/en not_active Expired - Lifetime
-
1995
- 1995-10-18 US US08/544,624 patent/US5679336A/en not_active Expired - Fee Related
-
1998
- 1998-02-25 GR GR980400386T patent/GR3026209T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69224071T2 (de) | 1998-05-07 |
| US5679336A (en) | 1997-10-21 |
| DK0604570T3 (da) | 1998-09-14 |
| ATE162081T1 (de) | 1998-01-15 |
| EP0604570A1 (en) | 1994-07-06 |
| ES2111083T3 (es) | 1998-03-01 |
| WO1993005816A1 (en) | 1993-04-01 |
| AU2672892A (en) | 1993-04-27 |
| EP0604570B1 (en) | 1998-01-14 |
| DE69224071D1 (de) | 1998-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3026209T3 (en) | Compositions containing quinolone antibiotics and sulfonate of polystyrol. | |
| NZ504017A (en) | Preparation of gatifloxacin and disodium edetate | |
| DE3574020D1 (en) | Stable salts of sam with polyanions | |
| AU8599091A (en) | Antimicrobial agents as well as substituted 2-cyclohexan-1-y1-amine derivatives and their preparation | |
| PE20010400A1 (es) | Formulacion de sal comun y moxifloxacina | |
| AU2387092A (en) | New pyrazine derivatives, their preparation and their use | |
| EP0712844A4 (en) | NOVEL CARBOXYLIC ACID COMPOUND WITH FUSED CORE OR SALT THEREOF, AND ITS USE IN MEDICINE | |
| DK0866791T3 (da) | Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler | |
| ES8704932A1 (es) | Procedimiento para preparar un derivado de acido quinoloncarboxilico | |
| ES2073222T3 (es) | Sales estables de acido 5,10-metilen-tetrahidrofolico. | |
| YU86792A (sh) | Rastvor sparfloksacina, njegovo dobijanje i so sparfloksacina kao komponenta rastvora | |
| ES550689A0 (es) | Procedimiento de preparar derivados de acidos carboxilicos substituidos | |
| EP1219296A4 (en) | SEBUM PRODUCTION INHIBITORS | |
| EP0842663A4 (en) | OPHTHALMIC PREPARATIONS | |
| DK251284D0 (da) | Substituerede 1,2,3-triazino(4',5'.4,5)thieno(2,3-b)-quinolin-4(3h)-oner eller syreadditionssalte deraf og deres fremstilling | |
| AU562643B2 (en) | N-arylpiperazine derivatives | |
| DE60006130D1 (de) | Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen | |
| DK0631777T3 (da) | Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning | |
| CA2308660A1 (en) | Stable aqueous pharmaceutical composition comprising tezosentan | |
| FI922482A (fi) | Foerfarande foer framstaellning av kinolinfoerening. | |
| UA43797A (uk) | Ін'єкційна форма препарату, що проявляє протиішемічну активність |